Galenica ends FY22 on a high….

20/01/23 -"Galenica reported estimate-beating FY22 sales growth of 4.7%, driven by an uptick in Products & Care (6.4%) as well as Logistics & IT (3.6%). The former benefited from continued momentum in ..."

Executive summary
Conflict of interest

Pages

Language

English

Published on

20/01/23

Download

You may also be interested by these reports :

16/09/25

Rexel

Our estimates have been trimmed as a result of the moderation of organic growth in recent quarters, which include volume-related challenges ...

10/09/25

Inditex

Inditex reported a slightly below-consensus H1 25 performance, but the new Autumn Winter collections have been very well received, with the top line ...

04/09/25

Currys

Currys reported a solid Q1 FY25/26 trading update, with group revenue up 3.0% yoy, in line with expectations. Positive investor sentiment is driven ...

25/08/25

HORNBACH Holding

We increase our TP to EUR 118.00 (prev.: EUR 95.00) – Add

EXECUTIVE SUMMARY

Updates

Pension Risks

Target & Opinion

Governance & Management

Business & Trends

Graphics : Momentum

Money Making

Graphics : MACD & Volumes

Debt

Graphics : Sensitivities

Valuation

Sector: Performance

DCF

Sector: Key data

NAV/SOTP

Sector: Ratios & Valorisation

Worth knowing

Sector: Peers

Financials

Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking

Trading in corporate shares

Analyst ownership

Advising of corporate (strategy, marketing, debt, etc)

Research paid for by corporate

Provision of corporate access paid for by corporate

Link between and a banking entity

Brokerage activity at AlphaValue